Atlas Trials

Compare the Prognostic Differences Between SBRT and Surgery for NSCLC Patients With Interlobular Fissure Invasion.

Clinical trial NCT06317324 · UNKNOWN

Trial details

NCT number
NCT06317324
Sponsor
Tianjin Medical University Cancer Institute and Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
NSCLCRadiotherapySurgery
Start date
2023-08-01
Primary completion
2024-08-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.